Cargando…
Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children
BACKGROUND: Treatment of clinical Plasmodium falciparum malaria with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) is associated with increased post-treatment gametocyte carriage. The effect of seasonal malaria chemoprevention (SMC) with SP and AQ on gametocyte carriage was assessed in asympto...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995796/ https://www.ncbi.nlm.nih.gov/pubmed/33771166 http://dx.doi.org/10.1186/s12936-021-03706-1 |
_version_ | 1783669982445436928 |
---|---|
author | Ahmad, Abdullahi Prom, Aurelia Bradley, John Ndiath, Mamadou Etoketim, Blessed Bah, Mamadou Van Geertruyden, Jean-Pierre Drakeley, Chris Bousema, Teun Achan, Jane D’Alessandro, Umberto |
author_facet | Ahmad, Abdullahi Prom, Aurelia Bradley, John Ndiath, Mamadou Etoketim, Blessed Bah, Mamadou Van Geertruyden, Jean-Pierre Drakeley, Chris Bousema, Teun Achan, Jane D’Alessandro, Umberto |
author_sort | Ahmad, Abdullahi |
collection | PubMed |
description | BACKGROUND: Treatment of clinical Plasmodium falciparum malaria with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) is associated with increased post-treatment gametocyte carriage. The effect of seasonal malaria chemoprevention (SMC) with SP and AQ on gametocyte carriage was assessed in asymptomatic P. falciparum infected children. METHODS: The study was carried out in eastern Gambia. Asymptomatic P. falciparum malaria infected children aged 24–59 months old who were eligible to receive SMC (SMC group) and children 5–8 years that were not eligible to receive SMC (comparison group) were recruited. Gametocytaemia was determined by molecular methods before and after SMC administration. Gametocyte carriage between the groups was compared using the chi-squared test and within-person using conditional logistic regression. RESULTS: During the 2017 and 2018 malaria transmission seasons, 65 and 75 children were recruited in the SMC and comparison groups, respectively. Before SMC administration, gametocyte prevalence was 10.7% (7/65) in the SMC group and 13.3% (10/75) in the comparison group (p = 0.64). At day 13 (IQR 12, 13) after SMC administration, this was 9.4% (5/53) in children who received at least the first dose of SMC treatment and 12.7% (9/71) for those in the comparison group (p = 0.57). Similarly, there was no difference in prevalence of gametocytes between children that adhered to all 3-day doses of SMC treatment 15.6% (5/32) and those in the comparison group (p = 0.68). In the SMC group, within-group gametocyte carriage was similar before and after SMC administration in children that received at least the first dose of SMC treatment (OR 0.6, 95% CI 0.14–2.51; p = 0.48) and in those that adhered to all 3-day doses of SMC treatment (OR 1.0, 95% CI 0.20–4.95; p = 1.0). CONCLUSION: In this study with relative low gametocyte prevalence prior to SMC treatment, no evidence was observed that SMC treatment increased gametocyte carriage in asymptomatic P. falciparum malaria infected children. |
format | Online Article Text |
id | pubmed-7995796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79957962021-03-30 Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children Ahmad, Abdullahi Prom, Aurelia Bradley, John Ndiath, Mamadou Etoketim, Blessed Bah, Mamadou Van Geertruyden, Jean-Pierre Drakeley, Chris Bousema, Teun Achan, Jane D’Alessandro, Umberto Malar J Research BACKGROUND: Treatment of clinical Plasmodium falciparum malaria with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) is associated with increased post-treatment gametocyte carriage. The effect of seasonal malaria chemoprevention (SMC) with SP and AQ on gametocyte carriage was assessed in asymptomatic P. falciparum infected children. METHODS: The study was carried out in eastern Gambia. Asymptomatic P. falciparum malaria infected children aged 24–59 months old who were eligible to receive SMC (SMC group) and children 5–8 years that were not eligible to receive SMC (comparison group) were recruited. Gametocytaemia was determined by molecular methods before and after SMC administration. Gametocyte carriage between the groups was compared using the chi-squared test and within-person using conditional logistic regression. RESULTS: During the 2017 and 2018 malaria transmission seasons, 65 and 75 children were recruited in the SMC and comparison groups, respectively. Before SMC administration, gametocyte prevalence was 10.7% (7/65) in the SMC group and 13.3% (10/75) in the comparison group (p = 0.64). At day 13 (IQR 12, 13) after SMC administration, this was 9.4% (5/53) in children who received at least the first dose of SMC treatment and 12.7% (9/71) for those in the comparison group (p = 0.57). Similarly, there was no difference in prevalence of gametocytes between children that adhered to all 3-day doses of SMC treatment 15.6% (5/32) and those in the comparison group (p = 0.68). In the SMC group, within-group gametocyte carriage was similar before and after SMC administration in children that received at least the first dose of SMC treatment (OR 0.6, 95% CI 0.14–2.51; p = 0.48) and in those that adhered to all 3-day doses of SMC treatment (OR 1.0, 95% CI 0.20–4.95; p = 1.0). CONCLUSION: In this study with relative low gametocyte prevalence prior to SMC treatment, no evidence was observed that SMC treatment increased gametocyte carriage in asymptomatic P. falciparum malaria infected children. BioMed Central 2021-03-26 /pmc/articles/PMC7995796/ /pubmed/33771166 http://dx.doi.org/10.1186/s12936-021-03706-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ahmad, Abdullahi Prom, Aurelia Bradley, John Ndiath, Mamadou Etoketim, Blessed Bah, Mamadou Van Geertruyden, Jean-Pierre Drakeley, Chris Bousema, Teun Achan, Jane D’Alessandro, Umberto Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children |
title | Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children |
title_full | Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children |
title_fullStr | Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children |
title_full_unstemmed | Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children |
title_short | Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children |
title_sort | gametocyte carriage after seasonal malaria chemoprevention in plasmodium falciparum infected asymptomatic children |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995796/ https://www.ncbi.nlm.nih.gov/pubmed/33771166 http://dx.doi.org/10.1186/s12936-021-03706-1 |
work_keys_str_mv | AT ahmadabdullahi gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren AT promaurelia gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren AT bradleyjohn gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren AT ndiathmamadou gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren AT etoketimblessed gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren AT bahmamadou gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren AT vangeertruydenjeanpierre gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren AT drakeleychris gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren AT bousemateun gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren AT achanjane gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren AT dalessandroumberto gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren |